Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jan Braune"'
Autor:
Evelyn Ramberger, Anna Dolnik, Yuen Lam Dora Ng, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Valeriia Sapozhnikova, Florian Grünschläger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florain Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Simon Haas, Dieter Beule, Ulrich Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
Publikováno v:
HemaSphere, Vol 7, p e4765105 (2023)
Externí odkaz:
https://doaj.org/article/af8c2740c79f49aabd27e1b42561787f
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
The majority of patients with acute myeloid leukemia (AML) with the NPM1 mutation achieve remission with intensive chemotherapy. However, many patients subsequently relapse, which occurs frequently within the first 2–3 years after therapy, while la
Externí odkaz:
https://doaj.org/article/8a7f78f9f2b04f0ebb7137d74d67ae70
Autor:
Julius Wehrle, Ulrike Philipp, Martina Jolic, Marie Follo, Saskia Hussung, Silvia Waldeck, Max Deuter, Michael Rassner, Jan Braune, Justyna Rawluk, Christine Greil, Cornelius F. Waller, Heiko Becker, Jesús Duque-Afonso, Anna L. Illert, Ralph M. Fritsch, Frank Meiss, Justus Duyster, Nikolas von Bubnoff, Florian Scherer
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 550 (2020)
Background: Circulating tumor DNA (ctDNA) in the blood plasma of cancer patients is an emerging biomarker used across oncology, facilitating noninvasive disease monitoring and genetic profiling at various disease milestones. Digital droplet PCR (ddPC
Externí odkaz:
https://doaj.org/article/e63030888c5d4ece9ce2c4dc54ca2dd8
Autor:
Guus J. J. E. Heynen, Francis Baumgartner, Michael Heider, Upayan Patra, Maximilian Holz, Jan Braune, Melanie Kaiser, Isabell Schäffer, Stefanos A. Bamopoulos, Evelyn Ramberger, Arunima Murgai, Yuen Lam Dora Ng, Uta Margareta Demel, Dominik Laue, Sven Liebig, Josefine Krüger, Martin Janz, Axel Nogai, Markus Schick, Philipp Mertins, Stefan Müller, Florian Bassermann, Jan Krönke, Ulrich Keller, Matthias Wirth
Publikováno v:
Blood Advances
Proteasome inhibition is a highly effective treatment for multiple myeloma (MM). However, virtually all patients develop proteasome inhibitor resistance, which is associated with a poor prognosis. Hyperactive small ubiquitin-like modifier (SUMO) sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e3785fe11be986954c96a6487cb6c9
http://edoc.mdc-berlin.de/21976/2/21976suppl.zip
http://edoc.mdc-berlin.de/21976/2/21976suppl.zip
Autor:
Dagmar von Bubnoff, Marie Follo, Florian Schiller, Jan Braune, Ulrike Philipp, Julius Wehrle, Frank Meiss, Michael Mix, Saskia Hussung, Erika Graf, Ralph Fritsch, Justus Duyster, David Rafei-Shamsabadi, Dietmar Pfeifer, Nikolas von Bubnoff, Laura Keller
Publikováno v:
JCO Precision Oncology. :20-31
PURPOSE We evaluated circulating tumor DNA (ctDNA) for detecting tumor burden in melanoma and examined whether early changes in the number of ctDNA copies predict response to treatment. PATIENTS AND METHODS We included 12 patients with stage III and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a669dcb2b67d0cf8c361ad80e42b66f
https://doi.org/10.1200/po.19.00174
https://doi.org/10.1200/po.19.00174
Autor:
Julia Fabienne Sandkühler, Xenia Kersting, Annika Faust, Eva Kathrin Königs, George Altman, Ulrich Ettinger, Silke Lux, Alexandra Philipsen, Helge Müller, Jan Brauner
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Creatine is an organic compound that facilitates the recycling of energy-providing adenosine triphosphate (ATP) in muscle and brain tissue. It is a safe, well-studied supplement for strength training. Previous studies have shown t
Externí odkaz:
https://doaj.org/article/6d5026cb013f49bd90e9be51f02ab9bf
Autor:
Florian Scherer, Ulrike Philipp, Julius Wehrle, Christine Greil, Jesus Duque-Afonso, Marie Follo, Jan Braune, Max Deuter, Cornelius F. Waller, Frank Meiss, Anna Lena Illert, Ralph Fritsch, Justyna Rawluk, Michael Rassner, Martina Jolic, Nikolas von Bubnoff, Heiko Becker, Saskia Hussung, Justus Duyster, Silvia Waldeck
Publikováno v:
Diagnostics
Volume 10
Issue 8
Diagnostics, Vol 10, Iss 550, p 550 (2020)
Volume 10
Issue 8
Diagnostics, Vol 10, Iss 550, p 550 (2020)
Background: Circulating tumor DNA (ctDNA) in the blood plasma of cancer patients is an emerging biomarker used across oncology, facilitating noninvasive disease monitoring and genetic profiling at various disease milestones. Digital droplet PCR (ddPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6cbba25b64c47f05dc310e87a36360
https://doi.org/10.3390/diagnostics10080550
https://doi.org/10.3390/diagnostics10080550
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Recent studies raised concerns over the state of AI benchmarking, reporting issues such as benchmark overfitting, benchmark saturation and increasing centralization of benchmark dataset creation. To facilitate monitoring of the health of the AI bench
Externí odkaz:
https://doaj.org/article/357a20a54edd4dfabde61f00141c7e58
Autor:
Jan Braune, Ulrike Philipp, Nikolas von Bubnoff, Frank Meiss, Erika Graf, Dagmar von Bubnoff, Dietmar Pfeifer, Marie Follo, Justus Duyster
Publikováno v:
Journal of Clinical Oncology. 36:12042-12042
12042Background: Available biomarkers LDH and S100B possess limited sensitivity and specificity to predict outcome in melanoma. In this pilot study we evaluated the use of circulating tumor (ct)DNA...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f489497b1eb9f30eb95c21485815787f
https://doi.org/10.1200/jco.2018.36.15_suppl.12042
https://doi.org/10.1200/jco.2018.36.15_suppl.12042
Autor:
Nikolas von Bubnoff, Dietmar Pfeifer, Felix Hahn, Justus Duyster, Laura Glaser, Dagmar von Bubnoff, Erika Graf, Jan Braune, Marie Follo, Frank Meiss, Ulrike Philipp
Publikováno v:
Journal of Clinical Oncology. 35:9564-9564
9564 Background: Available biomarkers LDH and S100B possess limited sensitivity and specificity to predict outcome in melanoma. In this pilot study we evaluated the use of circulating tumor (ct)DNA harboring BRAF and NRAS mutations as a predictive bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fc897fdfb40fe1d2a5fef7cd98b3e7b
https://doi.org/10.1200/jco.2017.35.15_suppl.9564
https://doi.org/10.1200/jco.2017.35.15_suppl.9564